1,027 material Form 8-K filings that 835 companies we cover made with the SEC in February 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Carlyle reported unaudited fourth-quarter and full-year 2024 results. Net income attributable to common stockholders was $211 million in Q4 and $1.0 billion for the year, compared with losses in the same periods of 2023. The board also declared a $0.35 quarterly dividend, with a February 21, 2025 record date and a February 28, 2025 payment date.
Q4 2024 net income attributable to common stockholders was $211 million, or $0.57 per diluted share, versus a loss of $692.0 million in Q4 2023.
FY 2024 net income attributable to common stockholders was $1.0 billion, or $2.77 per diluted share, versus a loss of $608.4 million in FY 2023.
Fee Related Earnings were $287 million in Q4 2024, up 13%, and $1.1 billion for FY 2024, up 29%.
Quarterly dividend of $0.35 per share is payable February 28, 2025 to holders of record on February 21, 2025.
Kilroy Realty reported fourth-quarter 2024 revenue of $286.4 million, up from $269.0 million a year earlier, and net income available to common stockholders of $59.5 million, or $0.50 per diluted share, versus $0.40. For the full year, revenue rose to $1,135.6 million, but net income available to common stockholders fell to $211.0 million, or $1.77 per diluted share, from $1.80, and FFO was $4.59 per diluted share versus $4.62. The company expects 2025 Nareit FFO of $3.85 to $4.05 per diluted share.
Q4 2024 FFO was $1.20 per diluted share, up from $1.08 a year earlier; quarterly leasing reached about 708,000 square feet, the highest quarterly volume since Q4 2019
Stabilized portfolio was 82.8% occupied at December 31, 2024, down from 85.0% a year earlier
Full-year 2024 net income available to common stockholders was $1.77 per diluted share versus $1.80 in 2023
2025 guidance: Nareit FFO of $3.85 to $4.05 per diluted share; same store NOI growth of (1.5%) to (3.0%)
Vornado Realty Trust reported fourth-quarter 2024 results. Net income attributable to common shareholders was $1.2 million, or $0.01 per diluted share, compared with a net loss of $61.0 million a year earlier, while revenue rose to $457.8 million from $441.9 million. Funds from operations (FFO), a key REIT profit measure, fell to $117.1 million, or $0.58 per diluted share, from $121.1 million, or $0.62.
Q4 2024 revenues were $457.8 million, up from $441.9 million in Q4 2023.
Q4 2024 FFO attributable to common shareholders was $117.1 million, or $0.58 per diluted share, versus $121.1 million, or $0.62, a year earlier.
Q4 2024 net income attributable to common shareholders was $1.2 million, or $0.01 per diluted share, versus a net loss of $61.0 million, or $0.32 per share.
For full-year 2024, FFO as adjusted was $447.1 million, or $2.26 per diluted share, versus $508.2 million, or $2.61, in 2023.
Watts Water Technologies reported fourth-quarter 2024 sales of $540 million, down 1% from a year earlier, with organic sales down 5%, while diluted EPS rose 21% to $2.02. For full year 2024, sales rose 10% to $2.25 billion and diluted EPS rose 11% to $8.69, but the company expects 2025 sales growth of down 3% to up 2%, a range that includes a decline.
Q4 2024 sales of $540 million, down 1% reported and down 5% organic; diluted EPS of $2.02, up 21%
Full year 2024 sales of $2.25 billion, up 10% reported and down 1% organic; diluted EPS of $8.69, up 11%
2025 outlook: sales growth of down 3% to up 2%; operating margin of 16.7% to 17.3%
I-CON Systems acquisition closed January 2, 2025; full year 2024 operating cash flow of $361 million
Moelis & Company's Compensation Committee approved a $25 million retention award of profits interest units to Chairman and CEO Ken Moelis, to be granted February 13, 2025. The award vests fully on February 13, 2029, subject to continued employment, and the units cannot be sold until twelve months after vesting, which ties his incentives to the company's longer-term results.
Retention award valued at $25 million, granted to Chairman and CEO Ken Moelis
Four-year cliff vesting on February 13, 2029, subject to continued employment
No sales permitted until the twelve-month anniversary of the vesting date
Unit count to be set using the average Class A share price from February 6 to February 12, 2025
On February 10, 2025, LegalZoom acquired 100% of Formation Nation for up to $64.75 million in cash and 2,205,445 restricted shares, with about $15.4 million of the cash held back for one year. The company also reported preliminary, unaudited 2024 results that it said were at the high end of its outlook range, but those figures may change before final results. Shareholders face dilution from the new shares, and the company expects the deal to add to Adjusted EBITDA and be accretive to Adjusted EPS in the first year.
Cash consideration of up to $64.75 million plus 2,205,445 restricted shares; $49.3 million cash paid at closing and about $15.4 million held back for one year
Preliminary Q4 2024 revenue of about $161.7 million and net income of about $12.9 million; full-year 2024 revenue of about $681.9 million and net income of about $30.0 million
Shares carry a two-year lock-up, with 50% released at each of the first and second anniversaries of closing
Full Q4 and full-year 2024 results and 2025 outlook are scheduled for a conference call on February 26, 2025
Harmonic reported unaudited fourth-quarter 2024 revenue of $222.2 million, up from $167.1 million a year earlier, and GAAP net income of $38.1 million, down from $83.8 million, which included a prior-year tax benefit. The company guided to 2025 GAAP net revenue of $585 million to $645 million and authorized a new $200 million share repurchase program through February 2028.
Q4 2024 GAAP diluted EPS was $0.32, versus $0.72 a year earlier; non-GAAP diluted EPS was $0.45, versus $0.13
Q4 2024 adjusted EBITDA was $71.8 million, versus $21.7 million a year earlier
2025 GAAP net revenue guidance is $585 million to $645 million, with GAAP net income of $22 million to $53 million
Board authorized a new $200 million buyback through February 2028, replacing the existing program
Universal Corp said preliminary results for the quarter ended December 31, 2024 show sales and other operating revenue of $937.2 million and diluted earnings per share of $2.27, but it has delayed its third-quarter earnings release and Form 10-Q. The delay follows an internal investigation into embezzlement at its Mozambique subsidiary, which has identified about $16.7 million in unauthorized payments over fiscal years 2016 through 2025, and the company expects to report one or more material weaknesses in internal control over financial reporting.
Preliminary quarter ended December 31, 2024: sales and other operating revenue $937.2 million, operating income $100.7 million, net income $57.1 million, diluted EPS $2.27.
Internal investigation has identified about $16.7 million in unauthorized payments in fiscal 2016 through 2025, including about $7 million in fiscal 2022 through 2025.
On February 10, 2025, lenders agreed to extend the deadline for delivering the quarterly financials to June 16, 2025; the company paid a consent fee of 0.05% of each consenting lender's commitment and term loans.
The company does not believe material adjustments to previously issued financial statements will be necessary, but it expects to report one or more material weaknesses in internal control over financial reporting.
Simpson Manufacturing reported fourth-quarter and full-year 2024 results on February 10, 2025. Full-year net sales rose 0.8% to $2.2 billion, but income from operations fell 9.5% to $430.0 million and diluted EPS fell 8.0% to $7.60, while fourth-quarter sales and EPS both rose. The company also initiated 2025 guidance with an operating margin of 18.5% to 20.5%, a midpoint below its stated 20% ambition.
Full-year 2024 net sales of $2.2 billion, up 0.8%; fourth-quarter net sales of $517.4 million, up 3.1%
Full-year 2024 operating margin of 19.3%, down from 21.5%; diluted EPS of $7.60 versus $8.26 in 2023
2025 outlook: operating margin of 18.5% to 20.5%, capital expenditures of $150.0 million to $170.0 million
Quarterly dividend of $0.28 per share; $50.0 million of stock repurchased in the fourth quarter
Medpace reported fourth-quarter 2024 revenue of $536.6 million, up 7.7%, and GAAP diluted earnings of $3.67 per share, up from $2.46 a year earlier. The board also approved a $600 million increase to the stock repurchase program, and the company forecast 2025 revenue of $2.110 billion to $2.210 billion, growth of 0.0% to 4.8%, for shareholders to weigh against slower new business awards.
Q4 2024 revenue was $536.6 million, up 7.7% from $498.4 million; GAAP net income was $117.0 million.
Q4 2024 net new business awards fell 13.8% to $529.7 million, for a net book-to-bill ratio of 0.99x.
2025 guidance: revenue of $2.110 billion to $2.210 billion and GAAP diluted EPS of $11.93 to $12.69.
On February 6, 2025, the board approved a $600 million increase to the stock repurchase program.
Edison International said its general counsel, Adam Umanoff, will retire effective July 4, 2025, and the board elected Chonda Nwamu as executive vice president and general counsel effective April 9, 2025. Umanoff will remain an executive vice president from April 9 through his retirement date, giving a planned handover period.
Adam S. Umanoff gave notice of retirement on February 7, 2025, effective July 4, 2025
Chonda J. Nwamu elected executive vice president and general counsel, effective April 9, 2025
Umanoff continues as executive vice president from April 9, 2025, until his retirement
Astera Labs reported preliminary fourth-quarter 2024 revenue of $141.1 million, up 25% from the prior quarter and up 179% from a year earlier, and GAAP net income of $24.7 million, or $0.14 per diluted share. For full-year 2024, revenue was $396.3 million, but the company reported a GAAP net loss of $83.4 million, which included $88.9 million of stock-based compensation tied to its IPO. The company also projected first-quarter 2025 revenue of $151 million to $155 million, which would be above the fourth-quarter level.
Q4 2024 revenue of $141.1 million, up 25% sequentially and up 179% year over year; GAAP net income of $24.7 million, or $0.14 per diluted share
Full-year 2024 revenue of $396.3 million, up 242%; GAAP net loss of $83.4 million, or $0.64 per share
Q1 2025 outlook: revenue of $151 million to $155 million; GAAP diluted EPS of $0.03 to $0.04; non-GAAP diluted EPS of $0.28 to $0.29
Coty reported fiscal second-quarter net revenue of $1,669.9 million, down 3% from a year earlier, with reported EPS of $0.02 versus $0.20, largely due to a $97 million equity swap mark-to-market hit. Adjusted operating income rose 8% to $333.7 million, and the company now expects FY25 adjusted EPS excluding the equity swap of $0.50-0.52, while forecasting reported FY25 sales to decline in the low single digits. A director also resigned on February 7, 2025, citing personal reasons.
Q2 reported net revenue of $1,669.9 million, down 3% year over year; like-for-like revenue down 1%
Q2 reported EPS of $0.02 versus $0.20 a year earlier; equity swap mark-to-market was a $0.11 negative impact
Q2 adjusted operating income of $333.7 million, up 8%; adjusted operating margin 20.0%
Board member Maria Asuncion Aramburuzabala Larregui resigned February 7, 2025, after four years, for personal reasons
SPS Commerce reported fourth-quarter and full-year 2024 results on February 10, 2025. Revenue grew 18% in the quarter and 19% for the year, but fourth-quarter net income fell to $17.6 million from $19.0 million. The company guided 2025 revenue to $758.0 million to $763.0 million, while its projected GAAP diluted EPS of $1.93 to $1.99 is below the $2.04 reported for 2024.
Q4 2024 revenue was $170.9 million, up from $145.0 million, with net income of $17.6 million ($0.46 per diluted share) versus $19.0 million ($0.51) a year earlier.
Full-year 2024 revenue was $637.8 million, up 19%, and net income was $77.1 million ($2.04 per diluted share), compared with $65.8 million ($1.76) in 2023.
2025 guidance calls for revenue of $758.0 million to $763.0 million and GAAP diluted EPS of $1.93 to $1.99.
First-quarter 2025 revenue is expected to be $178.5 million to $180.0 million.
Axcelis reported fourth-quarter 2024 revenue of $252.4 million and diluted EPS of $1.54, and full-year 2024 revenue of $1.02 billion, down from $1.13 billion in 2023. It guided first-quarter 2025 revenue to approximately $185 million and diluted EPS to approximately $0.38, well below fourth-quarter levels. Full-year diluted EPS fell to $6.15 from $7.43, and the company cited a near-term cyclical digestion period among its customers.
Q4 2024 revenue was $252.4 million, down from $310.3 million in Q4 2023 and $256.6 million in Q3 2024
Q4 2024 diluted EPS was $1.54, up from $1.49 in Q3 2024 but down from $2.15 in Q4 2023
Full-year 2024 revenue was $1.02 billion vs. $1.13 billion in 2023; diluted EPS was $6.15 vs. $7.43
Q1 2025 outlook: revenue of approximately $185 million and diluted EPS of approximately $0.38
Amkor Technology reported fourth quarter 2024 net sales of $1.63 billion, down from $1.75 billion a year earlier, and net income attributable to Amkor of $106 million, or $0.43 per diluted share, compared with $118 million, or $0.48, in the prior-year quarter. For full year 2024, net sales were $6.32 billion and diluted earnings per share were $1.43, both lower than in 2023. First quarter 2025 guidance of $1.225 billion to $1.325 billion in net sales and $0.01 to $0.17 per diluted share is below the fourth quarter results.
Q4 2024 net sales $1.63 billion, versus $1.75 billion in Q4 2023 and $1.86 billion in Q3 2024
Full year 2024 net income attributable to Amkor $354 million, or $1.43 per diluted share, versus $360 million, or $1.46, in 2023
Q1 2025 guidance: net income of $3 million to $43 million, or $0.01 to $0.17 per diluted share
Quarterly dividend raised 5% to $0.08269 per share, announced November 13, 2024; cash and short-term investments were $1.65 billion at December 31, 2024
Cincinnati Financial reported fourth-quarter 2024 net income of $405 million, down 66% from a year earlier, mainly because the fair value of equity securities it still holds declined. For the full year, net income rose 24% to $2.292 billion and non-GAAP operating income rose 26% to $1.197 billion, helped by higher property casualty underwriting profit. The company said its first-quarter 2025 results will be affected by the California wildfires.
Q4 2024 net income was $405 million, or $2.56 per share, versus $1.183 billion, or $7.50 per share, in Q4 2023; the company cited a $107 million after-tax decrease in the fair value of equity securities still held.
Full-year 2024 net income was $2.292 billion, or $14.53 per share, up from $1.843 billion, or $11.66 per share, in 2023.
Q4 2024 non-GAAP operating income rose 38% to $497 million, or $3.14 per share; full-year non-GAAP operating income rose 26% to $1.197 billion, or $7.58 per share.
Property casualty combined ratio improved to 84.7% in Q4 2024 from 87.5% a year earlier, and to 93.4% for full-year 2024 from 94.9% in 2023.
Arch Capital reported fourth-quarter 2024 net income available to common shareholders of $925 million, or $2.42 per diluted share, versus $2.3 billion, or $6.12 per share, a year earlier; the prior-year figure included a $1.18 billion deferred tax benefit. Net premiums earned rose 23.9% to $4.1 billion, but underwriting income fell 12.6% to $625 million as the combined ratio rose to 85.0% from 78.9%, driven by Hurricanes Milton and Helene. The company also estimated its share of the California wildfire insured loss at $450 million to $550 million.
Net income available to common shareholders was $925 million ($2.42 per share), versus $2.3 billion ($6.12 per share) in Q4 2023.
After-tax operating income was $866 million ($2.26 per share), versus $945 million ($2.49 per share) a year earlier.
Net premiums earned rose 23.9% to $4.1 billion; underwriting income fell 12.6% to $625 million and the combined ratio was 85.0% versus 78.9%.
Estimated share of California wildfire insured loss is $450 million to $550 million; book value per share was $53.11 at December 31, 2024, after a $5.00 special dividend paid December 4, 2024.
Brixmor reported fourth-quarter 2024 net income attributable to the company of $83.4 million, or $0.27 per diluted share, up from $0.24 a year earlier, and full-year net income of $1.11 per diluted share, up from $1.01. It also gave 2025 guidance of Nareit FFO of $2.19 to $2.24 per diluted share, compared with $2.13 for 2024, and same property NOI growth of 3.50% to 4.50%.
Q4 2024 Nareit FFO was $161.4 million, or $0.53 per diluted share, versus $0.51 in Q4 2023; same property NOI rose 4.7%.
Full-year 2024 Nareit FFO was $647.9 million, or $2.13 per diluted share, versus $2.04 in 2023.
2025 guidance: Nareit FFO of $2.19 to $2.24 per diluted share and same property NOI growth of 3.50% to 4.50%.
Board declared a quarterly dividend of $0.2875 per share, payable April 15, 2025 to holders of record on April 2, 2025.
Inspire Medical Systems reported fourth-quarter 2024 revenue of $239.7 million, up 25% from a year earlier, and diluted earnings per share of $1.15 versus $0.49. It also reaffirmed 2025 revenue guidance of $940 million to $955 million and introduced 2025 diluted EPS guidance of $2.10 to $2.20, which gives shareholders a profit target for the year.
Q4 2024 net income was $35.2 million, with diluted EPS of $1.15 versus $0.49 a year earlier
Full-year 2024 revenue was $802.8 million, up 28%, with net income of $53.5 million and diluted EPS of $1.75
2025 revenue guidance of $940 million to $955 million was reaffirmed; diluted EPS guidance of $2.10 to $2.20 was introduced
Q4 2024 gross margin was 85.0%, compared with 85.4% a year earlier
Lattice reported fourth-quarter 2024 revenue of $117.4 million, down 31.2% from a year earlier, and full-year revenue of $509.4 million, down 30.9%. GAAP diluted earnings were $0.12 per share in the quarter, against $0.71 a year earlier, and it guided first-quarter 2025 revenue to $115 million to $125 million. The company also appointed Lorenzo A. Flores as CFO effective February 10, 2025.
Q4 2024 revenue $117.4 million, down 7.6% from Q3 2024 and down 31.2% from Q4 2023; GAAP diluted EPS $0.12 versus $0.71 a year earlier
Full-year 2024 revenue $509.4 million versus $737.2 million in 2023; GAAP diluted EPS $0.44 versus $1.85
Q1 2025 outlook: revenue $115 million to $125 million; non-GAAP diluted EPS $0.20 to $0.24
Lorenzo A. Flores named SVP and CFO effective February 10, 2025, with a $600,000 base salary; Tonya Stevens moves to Chief Accounting Officer
Arrowhead Pharmaceuticals reported results for the fiscal 2025 first quarter ended December 31, 2024. Revenue was $2.5 million versus $3.551 million a year earlier, and the net loss attributable to the company widened to $173.1 million, or $1.39 per diluted share, from $132.9 million, or $1.24 per share. The company said it is funded into 2028 and cited the Sarepta licensing agreement and the plozasiran NDA acceptance as recent progress.
Revenue of $2.5 million for the quarter, compared with $3.551 million a year earlier
Net loss attributable to Arrowhead of $173.1 million, or $1.39 per diluted share, versus $132.9 million, or $1.24 per share, a year earlier
Total cash resources of $552.9 million at December 31, 2024, down from $681.0 million at September 30, 2024
Sarepta agreement provides $825 million upon closing, including $500 million in cash and a $325 million equity investment
Manhattan Associates said Eddie Capel will retire as President and CEO effective February 12, 2025, and be succeeded by Eric Clark, most recently CEO of NTT Data North America. Capel becomes Executive Vice-Chairman, and Clark joins the Board, which expands from eight to nine members. The filing discloses Clark's pay package, including a $800,000 base salary and an $8 million equity grant, and does not include any financial results.
Eric Clark succeeds Eddie Capel as President and CEO effective February 12, 2025
Clark's package includes an $800,000 base salary, an $800,000 target bonus and a $3 million cash signing bonus
Initial equity grant of restricted stock units valued at $8 million at grant, vesting through February 14, 2028
Capel joined Manhattan in June 2000 and has been CEO since January 2013
Sempra's Board of Directors appointed Anya Weaving and Kevin C. Sagara as directors on February 8, 2025, with appointments effective March 1, 2025. Ms. Weaving was named to the Audit and Compensation and Talent Development committees and was determined to be independent and an audit committee financial expert; Mr. Sagara, a former executive who retired in December 2023, was named to the Safety, Sustainability and Technology Committee and is not considered independent.
Anya Weaving, age 48, appointed to the Board; named to Audit Committee and Compensation and Talent Development Committee
Kevin C. Sagara, age 63, appointed to the Board; named to Safety, Sustainability and Technology Committee
Board determined Ms. Weaving is independent and an audit committee financial expert; Mr. Sagara is not independent due to his former role as Executive Vice President and Group President
Both directors will join Sempra's standard non-employee director compensation program
On February 10, 2025, Fox Corporation said John Nallen was named President and Chief Operating Officer, effective immediately, and extended his employment term through June 30, 2028. Starting July 1, 2025, his target annual bonus rises to $4,000,000 and his target annual equity award to $6,500,000, which increases the company's committed executive pay. The filing does not include any financial results.
Title changed from Chief Operating Officer to President and Chief Operating Officer, effective immediately
Employment term extended through June 30, 2028, approved by the Compensation Committee and Board on February 7, 2025
Target annual bonus and equity award rise to $4,000,000 and $6,500,000 starting July 1, 2025
After the term ends, Nallen becomes Special Advisor for three years at $600,000 per year
Insperity reported fourth quarter 2024 revenue up 2% to $1.6 billion but a net loss of $9 million, compared with net income of $19 million a year earlier. For full year 2024, revenue rose 1% to $6.6 billion while net income fell 47% to $91 million, and the company gave 2025 guidance of $3.10 to $3.95 in adjusted EPS, which reflects a higher effective income tax rate, and $240 million to $285 million in adjusted EBITDA.
Q4 2024 diluted EPS was $(0.22) versus $0.52 a year earlier; adjusted EPS was $0.05 versus $0.75
Full year 2024 diluted EPS was $2.42 versus $4.47; adjusted EPS was $3.58 versus $5.52
Operating expenses rose 17% in Q4 2024, including about $19 million tied to the Workday strategic partnership
Full year 2025 guidance: adjusted EPS of $3.10 to $3.95 and adjusted EBITDA of $240 million to $285 million
Roivant reported results for the quarter ended December 31, 2024. Revenue fell to $9.0 million from $15.6 million a year earlier, and the loss from continuing operations was $208.9 million, or $0.22 per share, compared with income of about $5.1 billion a year earlier, which included a one-time Telavant gain. Net income attributable to Roivant was $169.4 million, driven by a $327.0 million gain from discontinued operations tied to the sale of Dermavant to Organon.
Revenue, net was $9.0 million for the three months ended December 31, 2024, versus $15.6 million a year earlier.
R&D expenses rose $33.4 million to $141.6 million; G&A expenses rose $13.4 million to $141.5 million.
Income from discontinued operations was $327.0 million, reflecting the October 2024 sale of Dermavant to Organon.
Consolidated cash, cash equivalents, restricted cash and marketable securities were about $5.2 billion at December 31, 2024.
Incyte reported fourth-quarter 2024 total revenues of $1.2 billion, up 16% year over year, and full-year revenues of $4.2 billion, up 15%. Full-year GAAP net income fell to $32.6 million from $597.6 million, mainly because of a $679.4 million charge for in-process R&D assets acquired with Escient and a $100.0 million milestone payment to MacroGenics. The company also gave 2025 guidance for Jakafi and Opzelura net product revenues.
Q4 2024 GAAP net income was $201.2 million, or $1.02 per diluted share, versus $201.1 million, or $0.89, a year earlier
Full-year 2024 GAAP diluted EPS was $0.15, compared with $2.65 in 2023
2025 guidance: Jakafi net product revenues of $2,925 million to $2,975 million; Opzelura $630 million to $670 million
Cash, cash equivalents and marketable securities were $2.2 billion at December 31, 2024, down from $3.7 billion, mainly due to a $2.0 billion share repurchase in June 2024
Rockwell Automation reported fiscal first-quarter 2025 sales of $1,881 million, down 8.4% from a year earlier, with diluted EPS of $1.61, down 13%. The company lowered its fiscal 2025 reported sales growth range to (5.5)% to 0.5%, citing about (1.5)% of currency impact, while reaffirming its EPS guidance. Shareholders face lower quarterly sales and profit, though the company's EPS guidance was unchanged.
Sales were $1,881 million, down 8.4% from $2,052 million; organic sales fell 7.6%.
Diluted EPS was $1.61 versus $1.86 a year ago; adjusted EPS was $1.83 versus $2.04.
Fiscal 2025 reported sales growth guidance cut to (5.5)% to 0.5% from (4)% to 2%; diluted EPS guidance of $7.65 to $8.85 reaffirmed.
Orders rose about 10% year over year, and the company repurchased shares for $99 million in the quarter.
3M announced board changes: CEO William Brown will also become Chairman effective March 1, 2025, replacing Executive Chairman Michael Roman, who retires from the board that day and from the company on May 1, 2025. The board also added David Bozeman as an independent director effective February 6, 2025, while Amy Hood will not stand for re-election in 2025. The filing reports leadership and governance changes only, with no financial results.
William M. Brown, CEO, appointed Chairman of the Board effective March 1, 2025, in addition to his CEO role
Michael F. Roman retires as Executive Chairman and Director effective March 1, 2025, and serves as Executive Advisor until retiring from 3M on May 1, 2025
David P. Bozeman, President and CEO of C.H. Robinson Worldwide, elected to the Board effective February 6, 2025 and appointed to the Science, Technology and Sustainability Committee
Amy E. Hood does not intend to stand for re-election at the 2025 annual shareholder meeting
Edgewell reported first-quarter fiscal 2025 net sales of $478.4 million, down 2.1%, and a GAAP loss of $0.04 per diluted share, versus earnings of $0.09 a year earlier. The company lowered its full-year GAAP EPS outlook to $2.54 to $2.74 from $2.59 to $2.79, citing foreign currency changes, and said adjusted EPS will be toward the lower end of its $3.15 to $3.35 range. Shareholders also voted at the February 6, 2025 annual meeting, re-electing all ten director nominees and approving the auditor and executive pay proposals.
Net sales were $478.4 million versus $488.9 million a year earlier; organic net sales decreased 1.3%.
GAAP diluted EPS was $(0.04) versus $0.09; adjusted EPS was $0.07 versus $0.24, including a $0.17 unfavorable currency impact.
Full-year fiscal 2025 GAAP EPS outlook was lowered to $2.54 to $2.74 from $2.59 to $2.79; adjusted EPS is now expected toward the lower end of $3.15 to $3.35.
At the February 6, 2025 annual meeting, all ten director nominees were elected and PricewaterhouseCoopers LLP was ratified as auditor.
Loews reported fourth-quarter 2024 net income of $187 million, or $0.86 per share, down from $446 million, or $1.99 per share, a year earlier, after a $265 million CNA pension settlement charge. For full-year 2024, net income was $1,414 million, or $6.41 per share, compared with $1,434 million, or $6.29 per share, in 2023, and the company repurchased $611 million of its shares.
Q4 2024 net income was $187 million, or $0.86 per share, versus $446 million, or $1.99 per share, in Q4 2023
CNA pension settlement charge of $265 million after tax and noncontrolling interests, previously reported in October 2024
Full-year 2024 net income was $1,414 million, or $6.41 per share, versus $1,434 million, or $6.29 per share, in 2023
Loews repurchased 7.7 million shares for $611 million in 2024 and an additional 1.9 million shares for $164 million in early 2025
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.